Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
68 GBX | +2.26% | -4.23% | +36.00% |
Mar. 26 | EARNINGS: CAB Payments profit drops, Life Science REIT cuts dividend | AN |
Mar. 26 | BATM Advanced ink USD2.3 million orders | AN |
Strengths
- According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
Ratings chart - Surperformance
Sector: Business Support Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+36.00% | 86.81M | - | ||
+4.93% | 66.52B | B | ||
-3.06% | 44.49B | C- | ||
-0.32% | 31.69B | C- | ||
+8.45% | 21.62B | C+ | ||
-16.05% | 11.9B | A- | ||
-7.95% | 10.13B | C | ||
+20.46% | 9.63B | C+ | ||
-23.93% | 7.64B | B+ | ||
+303.14% | 5.71B | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- TRU Stock
- Ratings TruFin plc